Clinical Trials Directory

Trials / Terminated

TerminatedNCT01496235

Effect of Cocoa Consumption in Cardiovascular and Immune Parameters

Randomized Clinical Trial of the Effect of Cocoa Consumption in Cardiovascular and Immune Parameters in Colombian Patients With Newly Diagnosed Stage 1 Arterial Hypertension

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Universidad de Antioquia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Arterial hypertension is one of the most preventable risk factors for stroke, cardiovascular and renal disease. Cocoa is rich in a subclass of flavonoid called flavanol this increase nitric oxide production and is involved in controlling blood pressure.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDark chocolateEach chocolate bar provided 210 calories represented in 25 grams of carbohydrates, 3 g of proteins, 18 g of total fat and the presence of 70% cocoa solids
DIETARY_SUPPLEMENTWhite chocolateEach chocolate bar provided 230 calories represented in 28 grams of carbohydrates, 3 g of proteins, 18 g of total fat, without the presence of 70% cocoa solids

Timeline

Start date
2009-07-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2011-12-21
Last updated
2011-12-21

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT01496235. Inclusion in this directory is not an endorsement.

Effect of Cocoa Consumption in Cardiovascular and Immune Parameters (NCT01496235) · Clinical Trials Directory